Premium
Study indicates utility of genetic testing in schizophrenia
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30053
Subject(s) - schizophrenia (object oriented programming) , clozapine , genetic testing , medicine , antipsychotic , psychiatry , bioinformatics , biology
Patients with a well‐established genetic subtype of schizophrenia responded as well as other patients to treatment with the atypical antipsychotic clozapine but were more susceptible to potentially dangerous side effects, a new study has concluded. The results offer evidence of the utility of clinical genetic testing to guide treatment decisions for patients with schizophrenia.